IP Library Granted Patent US 9,029,147
Granted Patent B2
US 9,029,147 · App. 12/664,763 · Granted May 12, 2015

Methods and compositions for enhanced differentiation from embryonic stem cells

Inventors: Clark K. Colton (Newton, MA); Daryl E. Powers (Cambridge, MA); Jeffrey R. Millman (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
C12N5/0657C12N2500/25C12N2500/34C12N2500/38C12N2501/235C12N2506/02C12N2533/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,029,147
App. No.
12/664,763
Granted
May 12, 2015
Kind
B2
Abstract

The invention provides methods for differentiating pluripotent stem cells such as ES cells with improved progenitor and differentiated cell yield using low oxygen conditions and optionally in the absence of exogenously added differentiation factors.

Claims (21)

1. A method for enhancing mesoderm differentiation from pluripotent stem cells comprising

culturing pluripotent stem cells at a cell surface oxygen partial pressure that is less than 142 mmHg throughout a time period sufficient to induce mesoderm specific gene expression, wherein the cell surface oxygen partial pressure is about gas phase oxygen partial pressure,

wherein the pluripotent stem cells are mouse or human pluripotent stem cells,

wherein the pluripotent stem cells are cultured on a silicone rubber membrane.

2. The method of claim 1 , wherein the pluripotent stem cells are embryonic stem (ES) cells.

3. The method of claim 1 , wherein the pluripotent stem cells are cultured for at least 3 days.

4. The method of claim 1 , wherein the pluripotent stem cells are cultured for at least 6 days.

5. The method of claim 1 , wherein the pluripotent stem cells are cultured for 3-6 days.

6. The method of claim 1 , wherein the pluripotent stem cells are cultured for 5-15 days.

7. The method of claim 1 , wherein the cell surface oxygen partial pressure is less than 50 mmHg.

8. The method of claim 1 , wherein the cell surface oxygen partial pressure is less than 40 mmHg.

9. The method of claim 1 , wherein the cell surface oxygen partial pressure is less than 10 mmHg.

10. The method of claim 1 , further comprising a second culture step at a second cell surface oxygen partial pressure that is greater than the first cell surface oxygen partial pressure.

11. The method of claim 10 , wherein the second culture step is performed at a second cell surface oxygen partial pressure of 142 mmHg.

12. The method of claim 10 , wherein the second culture step is performed for at least 10 days.

13. A method for producing or enriching cardiomyocytes comprising

performing a first culture step comprising culturing ES cells at a first cell surface oxygen partial pressure that is about 36 mmHg for a first time period of 6 days,

performing a second culture step comprising culturing the ES cells at a second cell surface oxygen partial pressure that is 142 mmHg for a second time period that is about 15 days,

wherein cell surface oxygen partial pressure is about gas phase partial pressure in the first and second culture steps,

wherein the ES cells are mouse or human ES cells.

14. The method of claim 13 , wherein the ES cells are cultured on an oxygen permeable membrane.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 1, 2013
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029733/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2010
From: COLTON, CLARK K.; POWERS, DARYL E.; MILLMAN, JEFFREY R.
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 024081/0311 →
Continuity (3)
Provisional Application 60934742 · Jun 15, 2007
Provisional Application 61125041 · Apr 22, 2008
Related Publication 20100261277A1 · Oct 14, 2010